Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 467, pseudogene (RNU6-467P) is a genomic DNA sequence classified as a pseudogene of the U6 small nuclear RNA (snRNA) family[7]. U6 snRNA, the functional counterpart, is a critical RNA component of the spliceosome, involved in the splicing of precursor messenger RNA (pre-mRNA) in eukaryotes[5][1]. Pseudogenes such as RNU6-467P do not code for functional snRNA due to accumulated mutations or structural deficiencies and are typically regarded as non-coding genomic elements. They can arise through processes such as retrotransposition, often mediated by LINE-1 (L1) elements, resulting in dispersed, non-functional copies throughout the genome[3][8][9]. While most pseudogenes have no known biological function, some can exert regulatory effects on gene expression at the RNA level in rare contexts, though such roles are not described for RNU6-467P specifically[2]. There is no evidence that RNU6-467P acts as a therapeutic target, is implicated in disease biology, interacts with drugs, or serves as a clinically relevant biomarker[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 467, pseudogene (RNU6-467P).